BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 10731635)

  • 21. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.
    Dwivedi PP; Omdahl JL; Kola I; Hume DA; May BK
    J Biol Chem; 2000 Jan; 275(1):47-55. PubMed ID: 10617584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
    Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
    Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
    Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct repeat 3-type element lacking the ability to bind to the vitamin D receptor enhances the function of a vitamin D-responsive element.
    Ozono K; Yamagata M; Ohyama Y; Nakajima S
    J Steroid Biochem Mol Biol; 1998 Sep; 66(5-6):263-9. PubMed ID: 9749832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
    Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
    Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 20-epi side chain restores growth-regulatory and transcriptional activities of an A ring-modified hybrid analog of 1 alpha, 25-dihydroxyvitamin D3 without increasing its affinity to the vitamin D receptor.
    Peleg S; Liu YY; Reddy S; Horst RL; White MC; Posner GH
    J Cell Biochem; 1996 Nov; 63(2):149-61. PubMed ID: 8913867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.
    Raval-Pandya M; Dhawan P; Barletta F; Christakos S
    Mol Endocrinol; 2001 Jun; 15(6):1035-46. PubMed ID: 11376120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
    Ishizuka S; Kurihara N; Hiruma Y; Miura D; Namekawa J; Tamura A; Kato-Nakamura Y; Nakano Y; Takenouchi K; Hashimoto Y; Nagasawa K; Roodman GD
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):269-77. PubMed ID: 18501591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1alpha,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1alpha,25-dihydroxyvitamin D3: its production and metabolism in primary human keratinocytes.
    Astecker N; Reddy GS; Herzig G; Vorisek G; Schuster I
    Mol Cell Endocrinol; 2000 Dec; 170(1-2):91-101. PubMed ID: 11162893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activity profiles of 1alpha,25-dihydroxyvitamin D2, D3, D4, D7, and 24-epi-1alpha,25-dihydroxyvitamin D2.
    Tsugawa N; Nakagawa K; Kawamoto Y; Tachibana Y; Hayashi T; Ozono K; Okano T
    Biol Pharm Bull; 1999 Apr; 22(4):371-7. PubMed ID: 10328556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor.
    Jurutka PW; MacDonald PN; Nakajima S; Hsieh JC; Thompson PD; Whitfield GK; Galligan MA; Haussler CA; Haussler MR
    J Cell Biochem; 2002; 85(2):435-57. PubMed ID: 11948698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells.
    Rehan VK; Torday JS; Peleg S; Gennaro L; Vouros P; Padbury J; Rao DS; Reddy GS
    Mol Genet Metab; 2002 May; 76(1):46-56. PubMed ID: 12175780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
    Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
    J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
    Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
    J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
    Carvallo L; Henríquez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.